These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9784434)

  • 1. The use of hematological effects in the development of minimal risk levels.
    Abadin HG; Murray HE; Wheeler JS
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):61-6. PubMed ID: 9784434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health effects classification and its role in the derivation of minimal risk levels: renal effects.
    Chou CH; Pohl HR
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):202-8. PubMed ID: 15921839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health effects classification and its role in the derivation of minimal risk levels: developmental effects.
    Pohl HR; Smith-Simon C; Hicks H
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):55-60. PubMed ID: 9784433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilizing uncertainty factors in minimal risk levels derivation.
    Pohl HR; Abadin HG
    Regul Toxicol Pharmacol; 1995 Oct; 22(2):180-8. PubMed ID: 8577953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health effects classification and its role in the derivation of minimal risk levels: reproductive and endocrine effects.
    Pohl HR; Luukinen B; Holler JS
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):209-17. PubMed ID: 15921838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health effects classification and its role in the derivation of minimal risk levels: hepatic effects.
    Pohl HR; Chou CH
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):161-71. PubMed ID: 15869832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical risk assessment and uncertainty associated with extrapolation across exposure duration.
    Pohl HR; Chou CH; Ruiz P; Holler JS
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):18-23. PubMed ID: 19944126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating toxicologic end points to derive minimal risk levels for hazardous substances.
    Chou CH; Williams M; Jones D; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):71-5. PubMed ID: 12018018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health effects classification and its role in the derivation of minimal risk levels: immunological effects.
    Abadin HG; Chou CH; Llados FT
    Regul Toxicol Pharmacol; 2007 Apr; 47(3):249-56. PubMed ID: 17194513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public health guidance values for chemical mixtures: current practice and future directions.
    Pohl HR; Hansen H; Chou CH
    Regul Toxicol Pharmacol; 1997 Dec; 26(3):322-9. PubMed ID: 9441922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision of estimates of an ADI (or TDI or PTWI).
    Speijers GJ
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binary weight-of-evidence evaluations of chemical interactions--15 years of experience.
    Pohl HR; Mumtaz MM; Scinicariello F; Hansen H
    Regul Toxicol Pharmacol; 2009 Aug; 54(3):264-71. PubMed ID: 19445993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment and child health.
    Samet JM
    Pediatrics; 2004 Apr; 113(4 Suppl):952-6. PubMed ID: 15060187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of non-default uncertainty factors in the U.S. EPA's Integrated Risk Information System (IRIS). Part I: UF(L), UF(S), and "other uncertainty factors".
    Stedeford T; Zhao QJ; Dourson ML; Banasik M; Hsu CH
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(3):245-79. PubMed ID: 17763048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health effects classification and its role in the derivation of minimal risk levels: neurological effects.
    Chou CH; Williams-Johnson M
    Toxicol Ind Health; 1998; 14(3):455-71. PubMed ID: 9569449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pesticide residue analysis and its relationship to hazard characterisation (ADI/ARfD) and intake estimations (NEDI/NESTI).
    Renwick AG
    Pest Manag Sci; 2002 Oct; 58(10):1073-82. PubMed ID: 12400449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative estimates of risk for noncancer endpoints.
    Clewell HJ; Crump KS
    Risk Anal; 2005 Apr; 25(2):285-9. PubMed ID: 15876204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations and procedures in the derivation of ATSDR minimal risk levels.
    Wheeler JS; Chou S
    Vaccine; 2002 May; 20 Suppl 3():S51-5. PubMed ID: 12184367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Background to the ADI/TDI/PTWI.
    Herrman JL; Younes M
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S109-13. PubMed ID: 10597623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATSDR fact sheets on hazardous substances. Agency for Toxic Substances and Disease Registry.
    Public Health Rep; 2001; 116(3):271. PubMed ID: 12269227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.